Target HCV NS3 CD4+ Th1 epitope to major histocompatibility complex class II pathway

Biotechnology Letters

Volumn 28, Issue 1, 2006, Pages 3-8

  Gao, Ming ^a,b   Wang, Hai Ping ^b   Wang, Yan Ning ^b   Zhou, Yong ^a   Wang, Quan Li ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b Department of Hepatobilliary Surgery   (China)

Author keywords

DNA vaccine; Hepatitis C virus; Invariant chain

Indexed keywords

BIOCOMPATIBILITY; DNA; HISTOLOGY; POLYPEPTIDES; PROTEINS; VIRUSES;

CELL SURFACE; EXOCYTOSIS; INVARIANT CHAIN;

VACCINES;

EPITOPE; HLA ANTIGEN CLASS 2;

ANIMAL; ARTICLE; CD4+ T LYMPHOCYTE; CELL STRAIN 3T3; CELL STRAIN COS1; CERCOPITHECUS; GENETICS; HEPATITIS C VIRUS; IMMUNOLOGY; MOUSE; TH1 CELL;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CERCOPITHECUS AETHIOPS; COS CELLS; EPITOPES; HEPACIVIRUS; HISTOCOMPATIBILITY ANTIGENS CLASS II; MICE; NIH 3T3 CELLS; TH1 CELLS;

HEPATITIS C VIRUS;

EID: 29244483381     PISSN: 01415492     EISSN: 15736776     Source Type: Journal    
DOI: 10.1007/s10529-005-4679-0     Document Type: Article

References (15)

1. R Busch R Doebele NS Patil A Pashine ED Mellins 2000 Accessory molecules of MHC class II peptide loading Curr. Opin. Immunol. 12 99 106
2. ME Cramp S Rossol S Chokshi P Carucci R Williams NV Naoumov 2000 Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C Gastroenterology 118 346 355
3. HM Diepolder R Zachoval RM Hoffmann EA Wierenga T Santantonio MC Jung 1995 Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection Lancet 346 1006 1007
4. AE Esther van Tienhoven TB ten Brink J van Bergen F Koning W van Eden PM Broeren 2001 Induction of antigen specific CD4+ T cell responses by invariant chain based vaccines Vaccine 19 1515 1519
5. S Fujii S Senju YZ Chen M Ando S Matsushita Y Nishimura 1998 The CLIP-substituted invariant chain efficiently targets an antigenic peptide to HLA class II pathway in L cells Hum. Immunol. 59 607 614
6. JH Hoofnagle 1997 Hepatitis C: the clinical spectrum of disease Hepatology 26 15S 20S
7. G Malcherek C Wirblich N Willcox HG Rammensee J Trowsdale A Melms 1998 MHC class II-associated invariant chain peptide replacement by T cell epitopes: engineered invariant chain as a vehicle for directed and enhanced MHC class II antigen processing and presentation Eur. J. Immunol. 28 1524 1533
8. JG McHutchison SC Gorden ER Schiff 1998 Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C New. Engl. J. Med. 339 1485 1492
9. G Missale R Bertoni V Lamonaca A Valli M Massari C Mori MG Rumi M Houghton F Fiaccadori C Ferrari 1996 Diffrent clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response J. Clin. Invest. 98 706 714
10. T Nagata T Higashi T Aoshi M Suziki M Uchijima Y Koide 2002 Immunization with plasmid DNA encoding MHC class II binding peptide/CLIP-replaced invariant chain(Ii) induces specific helper T cells in vivo: the assessment of Ii p31 and p41 isoforms as vehicles for immunization Vaccine 20 105 114
11. T Poynard P Marcellin SS Lee 1998 Randomised trial of interferon a2b plus ribavirin for 48 weeks or for 24 weeks versus interferon a2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus Lancet 352 1426 1432
12. A Sponaas C Carstens N Koch 1999 C-terminal extension of the MHC class II-associated invariant chain by an antigenic sequence triggers activation of naive T cells Gene Ther. 6 1826 1834
13. SL Tsai YF Liaw MH Chen CY Huang GC Kuo 1997 Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity Hepatology 25 449 458
14. J van Bergen SP Schoenberger F Verreck R Amons R Offringa F Koning 1997 Efficient loading of HLA-DR with a T helper epitope by genetic exchange of CLIP Proc. Natl. Acad. Sci. USA 94 7499 7502
15. ZX Zhang DR Milich DL Peterson A Birkett R Schvarcz O Weiland M Sallberg 1997b Interferon-alpha treatment induces delayed CD4 proliferative responses to the hepatitis C virus nonstructural protein 3 regardless of the outcome of therapy J. Infect. Dis. 175 1294 1301